Business, Economics, Education, Entrepreneurs,
Environment, Science and Technology
 
Print Article Email Article
Posted February 15, 2008
____________________
Centres of Excellence

Government of Canada announces 11 new Centres of Excellence for Commercialization and Research <<

World-class centres will share $163 million to move discoveries out of the lab and onto the marketplace >>

OTTAWA - The Honourable Jim Prentice, Minister of Industry, today announced $163 million to establish 11 new Centres of Excellence for Commercialization and Research (CECRs). These centres will share $163 million to pursue major discoveries and bring them to the marketplace over the next five years.

"[The] announcement marks a milestone in Canadian research history," said Minister Prentice. "The technologies, therapies, services and products generated by these new centres will help improve the well-being of all Canadians while positioning Canada at the forefront of priority research areas. As we stated in our Science and Technology Strategy, this Government is committed to encouraging these exciting, multidisciplinary partnerships between the private, academic and public sectors."

The 11 CECRs and their funding amounts are: <<

- Advanced Applied Physics Solutions, Inc. (AAPS), Vancouver, BC --$14.95 million

- Bioindustrial Innovation Centre (BIC), Sarnia, ON--$14.95 million

- Centre for the Commercialization of Research (CCR), Ottawa, ON --$14.95 million

- Centre for Drug Research and Development (CDRD), Vancouver, BC --$14.95 million
- Centre of Excellence in Personalized Medicine (CEPM), Montreal, QC --$13.8 million
- Centre for Probe Development and Commercialization (CPDC), Hamilton, ON--$14.95 million
- Institute for Research in Immunology and Cancer/CECR in Therapeutics Discovery (IRICoR), Montreal, QC--$14.95 million
- MaRS Innovation, Toronto, ON--$14.95 million
- The Prostate Centre's Translational Research Initiative for Accelerated Discovery and Development (PC-TRIADD), Vancouver, BC--$14.95 million
- Pan-Provincial Vaccine Enterprise (PREVENT), Saskatoon, SK --$14.95 million
- CECR in the Prevention of Epidemic Organ Failure (PROOF), Vancouver, BC--$14.95 million

© Copyright 2008/Exchange Morning Post/Exchange Business Communications Inc.
Submit Press Release
Visitor Centre
Advertising Inquires
Email
Tel: 519.886.0298

Subscribe to Exchange Magazine